Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A
lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Your browser is not supported
Switch to Chrome, Edge, Firefox or Safari
This guide reviews child welfare, substance use disorder services, and courts to support cross-system coordination within state, county, and tribal jurisdictions. It considers the framework, population, legislation, funding sources, and services for each system.
This resource summarizes guidelines for screening, assessing, and providing comprehensive treatment for issues related to child abuse and neglect among people in substance use disorder treatment. It provides strategies for breaking the intergenerational cycle and discusses therapeutic issues for counselors.
This resource summarizes guidelines for screening, assessing, and providing comprehensive treatment for issues related to child abuse and neglect among people in substance use disorder treatment. It provides strategies for breaking the intergenerational cycle and discusses therapeutic issues for counselors.
Using a case study approach, this manual presents resources to better understand and engage the community in responding to children whose caregivers are negatively impacted by mental illness, substance use, or trauma.
This manual helps clinicians design and implement intensive outpatient treatment programs for people living with substance use disorder conditions. It discusses cultural competence and approaches, use of 12-step programs, cognitive behavioral therapy, and therapeutic communities.
This manual offers guidance on creating a substance use specialist program in child welfare offices or dependency courts. It includes case studies that showcase the programmatic and collaborative structure of substance use specialist programs.
This manual offers general principles to assist in the planning, delivery, and evaluation of pharmacologic approaches to support the recovery of people living with co-occurring disorders. It covers engagement, screening, assessment, treatment planning, and continuity of care.
